Journal Article Summary

The article investigates the effects of combining levetiracetam and topiramate on immune function, cognitive abilities, and neuronal nutritional status in children suffering from intractable epilepsy. This topic is important because intractable epilepsy can significantly impact a child's quality of life, and understanding how different treatments affect various health aspects can help improve patient outcomes. By exploring these effects, the study aims to provide insights into better management strategies for children with this challenging condition.

In this study, 124 children with intractable epilepsy were divided into two groups: one receiving only topiramate and the other receiving a combination of levetiracetam and topiramate. Researchers measured immune function by analyzing specific T cell counts and other biomarkers before and after treatment. The results showed that the group receiving the combination therapy had improved immune function, with higher levels of beneficial T cells and neurotrophic factors, as well as better cognitive scores compared to the control group. Importantly, the rates of adverse events were similar between both groups, suggesting that the combination therapy was safe.

However, the study has limitations, including its observational design and the relatively small sample size, which may affect the generalizability of the findings. Patients and caregivers should be aware that while the combination of levetiracetam and topiramate may offer benefits, individual responses can vary. It is crucial for readers to discuss any treatment options with a healthcare professional to ensure they are tailored to the child's specific needs and to monitor for any potential side effects.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Pan Danfeng, Li Xiaoxiao, Jiang Jinbiao, Luo Lingling. Effect of levetiracetam in combination with topiramate on immune function, cognitive function, and neuronal nutritional status of children with intractable epilepsy. American Journal of Translational Research 2021. PMID: 34650715. PMCID: PMC8506992.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]